Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateR…
Industry Peers
Medical Instruments & Supplies| Headline | Source | Time |
|---|---|---|
Older | ||
 Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates Sanara MedTech (SMTI) delivered earnings and revenue surprises of +150.00% and -4.30%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
 MiMedx (MDXG) Q2 2026 Earnings Call Transcript Surgical revenue grew 15% as wound care stabilized ahead of $350M Sanara deal. | ||
 biote Corp. (BTMD) Reports Break-Even Earnings for Q2 biote Corp. (BTMD) delivered earnings and revenue surprises of -100.00% and -5.71%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
 MiMedx Group, Inc. Q2 2026 Earnings Call Summary Moby summary of MiMedx Group, Inc.'s Q2 2026 earnings call | ||
MiMedx Group Inc (MDXG) (Q2 2026) Earnings Call Highlights: Surgical Growth and Transformative ... MiMedx reports strong surgical momentum and a transformational acquisition, while navigating a challenging wound care market with early signs of stabilization. | ||
 MiMedx Group Q2 Earnings Call Highlights MiMedx Group (NASDAQ:MDXG) said it has agreed to acquire Sanara MedTech in a transaction valued at $35 per Sanara share, a deal the company expects to close by the end of 2026. The announcement accompanied MiMedx’s second-quarter results, which showed sequential improvement in its wound-care busines | ||
 Sanara MedTech Inc. Q1 2026 Earnings Call Summary Moby summary of Sanara MedTech Inc.'s Q1 2026 earnings call | ||